T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

Clinical trial NCT00433407 · COMPLETED

Trial details

NCT number: NCT00433407
Sponsor: Jonsson Comprehensive Cancer Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Lung Cancer Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2005-08-01
Primary completion: 2006-02-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.